Anti-CXCR4 (phospho S339) antibody
| Name | Anti-CXCR4 (phospho S339) antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab74012 |
| Prices | $398.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB ELISA IHC-P ICC/IF ICC/IF |
| Species Reactivities | Mouse, Human |
| Antigen | Synthetic phosphopeptide derived from human CXCR4 around the phosphorylation site of serine 339 (H-S-SP-V-S) |
| Description | Rabbit Polyclonal |
| Gene | CXCR4 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Immunohistochemistry analysis of paraffin-embedded human brain carcinoma tissue using ab74012, at 1/50 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.
All lanes : Anti-CXCR4 (phospho S339) antibody (ab74012) at 1/500 dilutionLane 1 : Extracts from HUVEC cells treated with etoposide (25uM, 24hours)Lane 2 : Extracts from HUVEC cells treated with etoposide (25uM, 24hours) with the immunising phosphopeptide at 5 µgLysates/proteins at 5 µg per lane.
Immunofluorescence analysis of HeLa cells using ab74012, at 1/500 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.
Product References
Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive - Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive
Pitcher J, Abt A, Myers J, Han R, Snyder M, Graziano A, Festa L, Kutzler M, Garcia F, Gao WJ, Fischer-Smith T, Rappaport J, Meucci O. J Clin Invest. 2014 Feb;124(2):656-69.
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma - The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma
Buss MC, Remke M, Lee J, Gandhi K, Schniederjan MJ, Kool M, Northcott PA, Pfister SM, Taylor MD, Castellino RC. Oncogene. 2015 Feb 26;34(9):1126-40.
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) - PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3)
Decker S, Finter J, Forde AJ, Kissel S, Schwaller J, Mack TS, Kuhn A, Gray N, Follo M, Jumaa H, Burger M, Zirlik K, Pfeifer D, Miduturu CV, Eibel H, Veelken H, Dierks C. Mol Cancer Ther. 2014 May;13(5):1231-45.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the - Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the
Williams JL, Patel JR, Daniels BP, Klein RS. J Exp Med. 2014 May 5;211(5):791-9.
CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a - CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a
Brault L, Rovo A, Decker S, Dierks C, Tzankov A, Schwaller J. Leukemia. 2014 Mar;28(3):566-76.
Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 - Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10
Yang S, Edman LC, Sanchez-Alcaniz JA, Fritz N, Bonilla S, Hecht J, Uhlen P, Pleasure SJ, Villaescusa JC, Marin O, Arenas E. Development. 2013 Nov;140(22):4554-64.
HGF-induced PKCzeta activation increases functional CXCR4 expression in human - HGF-induced PKCzeta activation increases functional CXCR4 expression in human
Huang S, Ouyang N, Lin L, Chen L, Wu W, Su F, Yao Y, Yao H. PLoS One. 2012;7(1):e29124.
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in - Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in
Nasser MW, Qamri Z, Deol YS, Smith D, Shilo K, Zou X, Ganju RK. PLoS One. 2011;6(9):e23901.